SPRY: ARS Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SPRY: ARS Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,018.50
Enterprise Value ($M) 978.85
Book Value ($M) 200.98
Book Value / Share 2.07
Price / Book 5.07
NCAV ($M) 192.17
NCAV / Share 1.98
Price / NCAV 5.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.21

Liquidity (mrq)
Quick Ratio 12.52
Current Ratio 12.56

Balance Sheet (mrq) ($M)
Current Assets 208.79
Assets 217.60
Liabilities 16.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
06-17 13D/A Pratik Shah Living Trust dated June 15, 2011 5.40 -20.34
03-29 13D/A Ra Capital Management, L.p. 11.30 14.81
2024-02-09 13G/A Fmr Llc 1.25 -77.61

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANS
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-03 311,010 1,427,446 21.79
2025-02-28 178,841 677,042 26.42
2025-02-27 455,293 1,104,851 41.21
2025-02-26 950,574 1,735,170 54.78

(click for more detail)

Similar Companies
SIGA – SIGA Technologies, Inc. SKYE – Skye Bioscience, Inc.
SMMT – Summit Therapeutics Inc. STRO – Sutro Biopharma, Inc.
SUPN – Supernus Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io